Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Robert J. Irvin who wrote (279)	4/26/1999 8:11:00 PM
From: CPAMarty	Respond to of 496

short interest 4/15/1999 = 701,829 3/15/1999 = 663,281 % increase = 5.8

To: Robert J. Irvin who wrote (279)	4/27/1999 11:02:00 AM
From: Steve	Read Replies (1) \| Respond to of 496

No particular insight other than my observation that this company is going to need alot of capital to develop the drugs they want to develop. Furthermore, the pharmaceutical companies will be looking for new drugs to ignite revenue growth. Neuroscience may be an area of interest by the pharmaceuticals that they have yet to exploit.